Hi Eire2011,
You stated - 'Let's not get confused here' but after reading your post I was very confused so I thought you could clarify something for me...
1) RNA immuno-oncology with a partner or is it a collaboration?
2) The potential partnership with the phase 2 HSV 2 trial, 'What is an HSV 2 trial?
3) I think the rest of the post is good but the first two paragraphs didn't really make sense to me.
"Take a Closer Look", page-206
-
- There are more pages in this discussion • 1,022 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |